CClinicalTrials.gg
CompletedNCT07420699Updated Feb 19, 2026

The Acute Effects of Specialty Coffee on Cognitive Function in People With Type 2 Diabetes

An interventional study of Coffee in Type 2 Diabetes, sponsored by University of Reading. Completed at 1 site in United States. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by University of Reading · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Nov 2023, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
30 Years and older
Sex
All
01

Study summary

Coffee has been found to have beneficial effects on cognitive function and blood sugar control. Benefits include reduced risk of cognitive decline and improved performance on cognitive tests, as well as reduced risk of diabetes and improved blood sugar control in people with diabetes, a population that is at a higher risk of cognitive decline. These effects have been observed for both caffeinated and decaffeinated coffee, and have been associated with the polyphenol chlorogenic acid (CGA). This polyphenol has been found to be more bioavailable in certain coffees, known as "speciality coffee" as defined by the Specialty Coffee Association of America, depending on agriculture, roasting, and brewing method.

This current project will bring together these previous findings to explore the effects of specialty coffee on cognitive function in people with type 2 diabetes through a repeated measures trial with two conditions: a high CGA specialty coffee group and a conventional coffee control group. Participants will consume each beverage 1 week apart and will be tested before consumption, 5 hours after consumption, and 24 hours after consumption based on findings that CGA metabolism takes up to 36 hours. At the beginning and the end of each condition participants will undertake a cognitive assessment online using the Gorilla platform, and a series of questionnaires relating to health and mood measures (details in procedure).

In regard to key ethical issues, all participants will be coffee consumers therefore participants will be accustomed to consuming coffee and no adverse events are expected. The quantities of coffee to be consumed do not exceed the recommended daily intake of caffeine. The study will not impact on the participants ongoing management of their type 2 diabetes. Participants will be free to withdraw from the study any point without giving reason.

Read the detailed description

Following recruitment, interested participants will undertake an online screening session with the experimenter to check the inclusion and exclusion criteria (see section 3). Following this, study procedures will be explained in full by the experimenter and the participants will receive the information sheet (by email) and complete the consent form online. At this point, demographic information and chronic mood measures (BDI and GAD-7) will be collected. At the screening session participants will also undertake a practice version of the online cognitive tests, acute mood measure questionnaires, and an online 24 hour diet recall (ASA24) for familiarisation.

The cognitive tests will include digit span text entry, the digit symbol substitution task, Corsi blocks, and an auditory verbal learning test (AVLT). The standardised acute mood measures include the PANAS (outcome measures Positive and Negative Affect) and the Bond-Lader questionnaire (outcome measures alertness, attentiveness, and calmness). These will be adapted for online completion using the Gorilla platform. If able, participants will also self-report the following data relating to their glucose control and cardiovascular health to help characterise the sample: lipid panel (total cholesterol, HDL, LDL, and triglycerides) and HbA1C. Participants will have access this data from their routine type 2 diabetes consultations.

On test days, participants will log onto a video conference to meet with the researcher. They will complete the ASA24, cognitive battery, and acute mood measure questionnaires. Then participants will consume the provided coffee within 30 minutes. Participants will have either collected this coffee or have it posted to them alongside brewing equipment, standardised instructions for preparing, and a video demonstrating how to brew the coffee and use the equipment. Patients will log off the video call and will log back on 5 hours after finishing their coffee to undertake the cognitive battery and acute mood measures. No other coffee consumption is permitted during this time and participants will be instructed to consume a lunch low in CGA guided by a list of foods to avoid. They will log back on 24 hours after finishing their coffee to complete the cognitive battery and acute mood measures for the third and final time. For the third time point, participants will be instructed to consume the same breakfast and any coffee they had prior to meeting with the researcher at the first time point; coffee will be permitted in this instance to avoid withdrawal.

Upon completing the intervention, participants will be posed questions to explore attitudes about coffee drinking and blood sugar management.

02

Conditions studied

  • Type 2 Diabetes
03

In context

Diabetes Mellitus, Type 2

9,357 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.

This study's enrollment of 40 is below the median of 80 across 7,523 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

University of Reading is the lead sponsor of 146 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 30 years or more
  • Formal diagnosis of Type 2 Diabetes for 1 year or more
  • Current coffee drinkers, 4 or fewer cups daily (a cup is 8 oz)

Exclusion criteria

Exclusion Criteria:

  • Consuming on average more than 5 cups of coffee daily
  • Regularly consuming specialty coffee (participants will be provided with a list of these coffees)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Low Polyphenol coffee

    Participants will be provided with a conventional, low CGA coffee to brew and consume which contains less CGA than the experimental arm.

    Other: Coffee

  • Experimental
    High Polyphenol coffee

    Participants will be provided with a single origin, CGA rich specialty coffee as graded by the Specialty Coffee Association of America's Q-grading system to brew and consume

    Other: Coffee

Interventions

  • OtherCoffee

    12 ounces of coffee will be consumed

06

What researchers measure

Primary outcomes

  1. Short term Memory

    The Rey Auditory Verbal Learning Test (RAVLT) will present two lists of 15 words each, which will be played via audio recording after which participants will be asked to recite as many words as they can remember.

    Time frame: 0 hours

  2. Short term Memory

    The Digit Span Forward Task will show a series of numbers in a specific order which participants will be asked to type out in the order shown

    Time frame: 0 hours

  3. Short term Memory

    The Corsi Block Tapping task will present participants with a screen of blocks that light up in a sequence which participants will have to remember and tap the blocks in the order shown; the sequence lengthens or shortens based on participants performance.

    Time frame: 0 hours

  4. Processing Speed

    A computerised version of the Digit Symbol Substitution Test (DSST) will be used to assess processing speed. Participants will be given a legend with numbers corresponding to symbols, then presented with a specific pair of number/symbol. They will then determine if that pair is a match or a mismatch, and respond accordingly. They will be measured for speed and accuracy.

    Time frame: 0 hours

  5. Processing Speed

    A computerised version of the Digit Symbol Substitution Test (DSST) will be used to assess processing speed. Participants will be given a legend with numbers corresponding to symbols, then presented with a specific pair of number/symbol. They will then determine if that pair is a match or a mismatch, and respond accordingly. They will be measured for speed and accuracy.

    Time frame: 5 hours

  6. Processing Speed

    A computerised version of the Digit Symbol Substitution Test (DSST) will be used to assess processing speed. Participants will be given a legend with numbers corresponding to symbols, then presented with a specific pair of number/symbol. They will then determine if that pair is a match or a mismatch, and respond accordingly. They will be measured for speed and accuracy.

    Time frame: 24 hours

  7. Long Term Memory

    Long term memory will be assessed using the Rey Auditory Verbal Learning Test (RAVLT), where participants will be asked to recall as many words as possible from the previous two lists words heard earlier.

    Time frame: 0 hours

  8. Long Term Memory

    Long term memory will be assessed using the Rey Auditory Verbal Learning Test (RAVLT), where participants will be asked to recall as many words as possible from the previous two lists words heard earlier.

    Time frame: 5 hours

  9. Long Term Memory

    Long term memory will be assessed using the Rey Auditory Verbal Learning Test (RAVLT), where participants will be asked to recall as many words as possible from the previous two lists words heard earlier.

    Time frame: 24 hours

  10. Source Monitoring

    Source monitoring will be assessed using a modified version of the Rey Auditory Verbal Learning Test (RAVLT) where a third "distractor" list will be presented, after which participants will be asked to recognize if a word is one heard in the original two lists, or a new word. If participants respond the former, they will then be asked to identify which list they heard the word from.

    Time frame: 0 hours

  11. Source Monitoring

    Source monitoring will be assessed using a modified version of the Rey Auditory Verbal Learning Test (RAVLT) where a third "distractor" list will be presented, after which participants will be asked to recognize if a word is one heard in the original two lists, or a new word. If participants respond the former, they will then be asked to identify which list they heard the word from.

    Time frame: 5 hours

  12. Source Monitoring

    Source monitoring will be assessed using a modified version of the Rey Auditory Verbal Learning Test (RAVLT) where a third "distractor" list will be presented, after which participants will be asked to recognize if a word is one heard in the original two lists, or a new word. If participants respond the former, they will then be asked to identify which list they heard the word from.

    Time frame: 24 hours

  13. Short term Memory

    The Rey Auditory Verbal Learning Test (RAVLT) will present two lists of 15 words each, which will be played via audio recording after which participants will be asked to recite as many words as they can remember.

    Time frame: 5 hours

  14. Short term Memory

    The Corsi Block Tapping task will present participants with a screen of blocks that light up in a sequence which participants will have to remember and tap the blocks in the order shown; the sequence lengthens or shortens based on participants performance.

    Time frame: 5 hours

  15. Short term Memory

    The Digit Span Forward Task will show a series of numbers in a specific order which participants will be asked to type out in the order shown

    Time frame: 5 hours

  16. Short term Memory

    The Rey Auditory Verbal Learning Test (RAVLT) will present two lists of 15 words each, which will be played via audio recording after which participants will be asked to recite as many words as they can remember.

    Time frame: 24 hours

  17. Short term Memory

    The Digit Span Forward Task will show a series of numbers in a specific order which participants will be asked to type out in the order shown

    Time frame: 24 hours

  18. Short term Memory

    The Corsi Block Tapping task will present participants with a screen of blocks that light up in a sequence which participants will have to remember and tap the blocks in the order shown; the sequence lengthens or shortens based on participants performance.

    Time frame: 24 hours

Secondary outcomes

  1. Mood

    Positive affect will be measured using the Positive and Negative Affect Schedule (PANAS). The ratings (a scale of 1-5) for the 10 positive items will be summed to get a Positive Affect (PA) score. Scores can range from 10 to 50, with higher scores indicated higher levels of PA

    Time frame: 0 hours

  2. Mood

    Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). The ratings (a scale of 1-5) for the 10 negative items will be summed to get a Negative Affect (NA) score. Scores can range from 10 to 50, with higher scores indicated higher levels of PA

    Time frame: 0 hours

  3. Mood

    Mood will be measured using the Bond-Lader Visual Analogue Scale (BL-VAS) where participants rate their mood by marking a continuous line between two extreme endpoints, typically ranging from "not at all" to "extremely." The values are averaged into three categories (alertness, contentedness, and calmness) and higher scores indicate higher experiencing of each category.

    Time frame: 0 hours

  4. Mood

    Mood will be measured using the Immediate Mood Scaler (IMS), which captures current mood states using 7-point Likert scales. The total score is calculated by summing all 22 items, with higher scores indicating more negative mood states

    Time frame: 0 hours

  5. Mood

    Positive affect will be measured using the Positive and Negative Affect Schedule (PANAS). The ratings (a scale of 1-5) for the 10 positive items will be summed to get a Positive Affect (PA) score. Scores can range from 10 to 50, with higher scores indicated higher levels of PA

    Time frame: 5 hours

  6. Mood

    Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). The ratings (a scale of 1-5) for the 10 negative items will be summed to get a Negative Affect (NA) score. Scores can range from 10 to 50, with higher scores indicated higher levels of PA

    Time frame: 5 hours

  7. Mood

    Mood will be measured using the Bond-Lader Visual Analogue Scale (BL-VAS) where participants rate their mood by marking a continuous line between two extreme endpoints, typically ranging from "not at all" to "extremely." The values are averaged into three categories (alertness, contentedness, and calmness) and higher scores indicate higher experiencing of each category.

    Time frame: 5 hours

  8. Mood

    Mood will be measured using the Immediate Mood Scaler (IMS), which captures current mood states using 7-point Likert scales. The total score is calculated by summing all 22 items, with higher scores indicating more negative mood states

    Time frame: 5 hours

  9. Mood

    Positive affect will be measured using the Positive and Negative Affect Schedule (PANAS). The ratings (a scale of 1-5) for the 10 positive items will be summed to get a Positive Affect (PA) score. Scores can range from 10 to 50, with higher scores indicated higher levels of PA

    Time frame: 24 hours

  10. Mood

    Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). The ratings (a scale of 1-5) for the 10 negative items will be summed to get a Negative Affect (NA) score. Scores can range from 10 to 50, with higher scores indicated higher levels of PA

    Time frame: 24 hours

  11. Mood

    Mood will be measured using the Bond-Lader Visual Analogue Scale (BL-VAS) where participants rate their mood by marking a continuous line between two extreme endpoints, typically ranging from "not at all" to "extremely." The values are averaged into three categories (alertness, contentedness, and calmness) and higher scores indicate higher experiencing of each category.

    Time frame: 24 hours

  12. Mood

    Mood will be measured using the Immediate Mood Scaler (IMS), which captures current mood states using 7-point Likert scales. The total score is calculated by summing all 22 items, with higher scores indicating more negative mood states

    Time frame: 24 hours

07

Study locations

1 site
  • Berkeley
    Berkeley, California 94720, United States
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07420699
Lead sponsor
University of Reading
Responsible party
Daniel Lamport (Associate Professor, University of Reading) — Principal investigator
First posted
Feb 19, 2026
Start date
Nov 9, 2023
Primary completion
Aug 23, 2024
Completion
Aug 23, 2024
Last update
Feb 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion